BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/1/2024 6:03:24 AM | Browse: 128 | Download: 860
 |
Received |
|
2024-03-09 11:38 |
 |
Peer-Review Started |
|
2024-03-09 11:38 |
 |
First Decision by Editorial Office Director |
|
2024-04-17 09:45 |
 |
Return for Revision |
|
2024-04-17 09:45 |
 |
Revised |
|
2024-05-14 09:01 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-06-03 02:44 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-06-03 10:12 |
 |
Articles in Press |
|
2024-06-03 10:12 |
 |
Edit the Manuscript by Language Editor |
|
2024-06-11 19:39 |
 |
Typeset the Manuscript |
|
2024-06-27 06:42 |
 |
Publish the Manuscript Online |
|
2024-07-01 06:03 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Retrospective Study |
| Article Title |
Technetium-99m-methylene diphosphonate single photon emission computed tomography/computed tomography combined with prostate-specific antigen/free prostate-specific antigen ratio for bone metastasis of prostate cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian He, Yi-Pu Zhong and Shuang Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shuang Zhang, MAMS, Doctor, Doctor, Department of Nuclear Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shierqiao Road, Chengdu 610072, Sichuan Province, China. shudufeiji7177441@163.com |
| Key Words |
Matrix metalloproteinase 9; Single photon emission computed tomography; Prostate-specific antigen to free prostate-specific antigen ratio; Prostate cancer; Bone metastasis |
| Core Tip |
This work investigated the diagnostic value of technetium-99m-methylene diphosphonate (99mTc-MDP) single-photon emission computed tomography/computed tomography (SPECT/CT) imaging combined with the serum prostate-specific antigen (PSA)/free PSA ratio for detecting bone metastasis in prostate cancer. Compared to individual methods, the combination of SPECT/CT imaging and PSA/fPSA ratio demonstrated significantly higher positive predictive values and specificity. The PSA/fPSA ratio in prostate cancer bone metastasis (PCBM) patients was notably lower than in non-PCBM patients. The integrated approach achieved a 95% detection rate for PCBM, emphasizing its diagnostic efficacy. |
| Publish Date |
2024-07-01 06:03 |
| Citation |
He J, Zhong YP, Zhang S. Technetium-99m-methylene diphosphonate single photon emission computed tomography/computed tomography combined with prostate-specific antigen/free prostate-specific antigen ratio for bone metastasis of prostate cancer. World J Clin Cases 2024; 12(20): 4082-4090 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i20/4082.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i20.4082 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.